Opinion|Videos|May 19, 2025
Navigating ALK Inhibitor Toxicities
Panelists discuss how ALK inhibitors compare in terms of tolerability and best practices for managing associated toxicities.
Advertisement
Episodes in this series
ALK Inhibitor Tolerability and Toxicity Management
Key Themes:
- Tolerability comparison among available ALK inhibitors
- Best practices for managing treatment-associated toxicities
- Patient management strategies
Notable Insights:
- Castronovo compared the tolerability profiles of various ALK inhibitors
Grizzard shared best practices for toxicity management
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5
